Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue microarray technology for high-throughput molecular profiling of cancer.

O P Kallioniemi1, U Wagner, J Kononen

  • 1Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, 49 Convent Drive, Room 4A24, MSC 4465, Bethesda, MD 20892, USA. okalli@nhgri.nih.gov

Human Molecular Genetics
|March 21, 2001
PubMed
Summary

Tissue microarray (TMA) technology enables rapid, high-throughput analysis of molecular targets in thousands of tissue specimens. This accelerates genomics-based diagnostics and drug discovery, particularly in cancer research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective analysis of real-world clinical use of comprehensive genomic profiling in solid tumors in Finland 2017-2020.

ESMO real world data and digital oncology·2026
Same author

From wind to seismic signature captured by seismometers in lake Lucerne.

Scientific reports·2025
Same author

Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

World journal of urology·2020
Same author

The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.

Oncogene·2017
Same author

MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays.

Journal of mass spectrometry : JMS·2017
Same author

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Area of Science:

  • Biotechnology
  • Genomics
  • Molecular Pathology

Background:

  • Tissue microarray (TMA) technology offers a powerful method for analyzing molecular targets across numerous tissue samples simultaneously.
  • It enables simultaneous assessment at DNA, RNA, or protein levels, bridging molecular discoveries with clinical applications.

Purpose of the Study:

  • To highlight the advantages and applications of TMA technology in research and diagnostics.
  • To emphasize its role in genomics-based discovery and drug target identification.

Main Methods:

  • Utilizes TMA technology for high-throughput analysis of molecular targets (DNA, RNA, protein) in thousands of tissue specimens.
  • Leverages automation for increased throughput and analysis of archival tissues.

Related Experiment Videos

Main Results:

  • TMAs significantly increase the speed of molecular analyses (over 100-fold) compared to conventional methods.
  • Preserves precious tissues and allows analysis of a vast number of targets from consecutive sections.
  • Facilitates the study of archival specimens, expanding their utility in genomic and proteomic surveys.

Conclusions:

  • TMA technology is ideal for genomics-based diagnostics and drug target discovery due to its efficiency and ability to analyze large cohorts.
  • Its applications are prominent in cancer research, aiding in the analysis of molecular alterations, tumor progression, and validation of new therapeutic targets.